Pharmaceutical Raw Materials
Veterinary API
Antiallergic Drugs
Hormones and Endocrine Drugs
Drug Metabolism
Pharmaceutical Intermediates
Synthetic Anti Infective Drugs
Specialty Drugs
Vitamins and Minerals Medicines
Feed Drug Additive
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Diagnostic Agents
Anti Stress Drugs
Antipyretic Analgesics
Antiparasitic Drugs
Circulatory System Drugs
Biochemicals
Blood System Drugs
Immune System Medication
Pharmaceutical Excipients
Fluid, Electrolyte, and Acid-Base Balance
Urinary System Drugs
Antibiotics
Anesthetic Agents
Inhibitors
Other Chemical Drugs
Digestive System Drugs
CAS:654671-77-9
Molecular Formula:C16H20F6N5O6P
Alias
More Information
Sitagliptin Phosphate Hydrate; 7-[(3R)-3-Amino-1-Oxo-4-(2,4,5-Trifluorophenyl)Butyl]-5,6,7,8-Tetrahydro-3-(Trifluoromethyl)-1,2,4-Triazolo[4,3-A]Pyrazinephosphatemonohydrate; 3(R)-3-Amino-1-[3-(Trifluoromethyl)-5H,6H,7H,8H [1,2,4]Triazolo[4,3-A]Pyrazin-7-Yl]-4-(2,4,5-Trifluorophenyl)Butan-1-One Phosphate Monohydrate; (2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-Dihydro[1,2,4]Triazolo[4,3-A]Pyrazin-7(8H)-Yl]-1-(2,4,5-Trifluorophenyl)Butan-2-Amine Dihydrogenphosphate Monohydrate; Sitagliptin Phosphate (Usan); Januvia (Tn); Sitagliptin Monohydrate; Sitagliptin Phosphate.H2O; Sitagliptin Monophosphate Monohydrate; (R)-3-Amino-1-(3-(Trifluoromethyl)-5,6-Dihydro-[1,2,4]Triazolo[4,3-A]Pyrazin-7(8H)-Yl)-4-(2,4,5-Trifluorophenyl)Butan-1-One Phosphate Hydrate
Brief Introduction
It is very effective for the treatment of type 2 diabetes. As a new type of antidiabetic drug, CP has a Glucose dependent effect, a moderate hypoglycemic effect, no increase in insulin secretion at the same time without hypoglycemia, effective relief of hunger and other advantages, and no nausea, vomiting, edema and increased body weight and other side effects.
Suppliers
View More Vendors (2） >
CAS:661-19-8
Molecular Formula:C22H46O
Alias
More Information
Ik2; Emery 3304; Tadenan; Jarcol 22; Docosan-1-Ol; Behenic Alcohol; N-Docosanol; Docosanol; Behenyl Alcohol; Alcohol C22; Docosanol (Abreua); Lidavol; Docosanyl Alcohol
Brief Introduction
Anti herpesvirus. It is widely used in personal care, washing and health care products.
Suppliers
View More Vendors (2） >
CAS:67-20-9
Molecular Formula:C8H6N4O5
Alias
More Information
1-(((5-Nitro-2-Furanyl)Methylene)Amino)-2,4-Imidazolidinedione; 1-(5-Nitro-2-Furfurylideneamino)Hydantoin; 1-[(5-Nitrofurfurylidene)Amino]Hydantoin; Furadoxyl
Brief Introduction
It is a good antibacterial.
Suppliers
View More Vendors (2） >
Alias
More Information
1,2,3,4,5,6-Hexanehexol; (2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-Hexol; D-Mannitol; 69658 Mannitol
Brief Introduction
This product is used as dehydrating agent and diuretic in medicine. It is used to reduce intracranial pressure, intraocular pressure, diuresis and prevent early acute renal insufficiency. It is also used as excipient of tablet. It can be used as analytical reagent, resin and medicine. It can be used as sweetener (low calorie, low sweetness); Nutritional supplements; Quality improver; Cake, gum and other antisticking agents; Heat preservation agent.
Suppliers
View More Vendors (2） >
CAS:73590-58-6
Molecular Formula:C17H19N3O3S
Alias
More Information
5-Methoxy-2-[(4-Methoxy-3,5-Dimethyl-Pyridin-2-Yl)-Methylsulfinyl]Benzimidazole; Losec; Zimor; Antra; Aulcer; Zoltum; Miol; Elgam; Prysma; Mepral; Ulcsep; 1H-Benzimidazole,5-Methoxy-2-(((4-Methoxy-3,5-Dimethyl-2-Pyridinyl)Methyl)Sulf; 2-Chloromethyl-3,5-Dinmethyl-4-Methoxypyridine
Brief Introduction
Omeprazole is a proton pump inhibitor used in the treatment of peptic ulcer and gastroesophageal reflux disease. It can specifically act on the site of proton pump in gastric parietal cells and convert into the active form of sulphonamide. Then it can irreversibly combine with the sulfhydryl group of proton pump through disulfide bond to form a complex of sulphonamide and proton pump (H + - K + - ATPase), Therefore, inhibiting the activity of the enzyme can prevent the H + in parietal cells from being transported to the gastric cavity, and block the last step of gastric acid secretion, which can greatly reduce the amount of gastric acid in gastric juice. Therefore, this product has a strong and lasting inhibitory effect on gastric acid secretion caused by various reasons (such as basic gastric acid secretion, gastric acid secretion caused by histamine, pentagastrin and stimulation of vagus nerve, including gastric acid secretion caused by dibutyl camp, which cannot be inhibited by H2 receptor blockers). This is related to the irreversibility of the inhibitory effect of the product on proton pump. Only after the formation of a new proton pump can the acid secretion recover.
Suppliers
View More Vendors (2） >
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!